Evidence map›Paper›PMID 30105001›Full record

ReviewFrontiers in endocrinology2018

Critical Enzymatic Functions of FTO in Obesity and Cancer.

Xiaolan Deng, Rui Su, Savanna Stanford, Jianjun Chen

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression.Journal of experimental & clinical cancer research : CR · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. The effects of NMolecular and cellular biochemistry · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Screening of Exons 4-9 Polymorphisms ofArchives of Razi Institute · 2023
    Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Xiaolan DengDepartment of Systems Biology and The Gehr Family Center for Leukemia Research, Beckman Research Institute of City of Hope Monrovia, CA, United States.
Rui SuDepartment of Systems Biology and The Gehr Family Center for Leukemia Research, Beckman Research Institute of City of Hope Monrovia, CA, United States.
Savanna StanfordDepartment of Systems Biology and The Gehr Family Center for Leukemia Research, Beckman Research Institute of City of Hope Monrovia, CA, United States.
Jianjun ChenDepartment of Systems Biology and The Gehr Family Center for Leukemia Research, Beckman Research Institute of City of Hope Monrovia, CA, United States.
Beckman Research InstituteCity of Hope · US

Funding

Targeting TET1 signaling to treat acute myeloid leukemiaR01CA211614 · NCI · UNIVERSITY OF CINCINNATI · PI CHEN, JIANJUN · 2017 to 2021
$2.3M
The role and mechanism of FTO in leukemogenesis and drug responseR01CA214965 · NCI · UNIVERSITY OF CINCINNATI · PI CHEN, JIANJUN · 2017 to 2021
$2.1M
The role and functional mechanism of TET1 in MLL-rearranged leukemiaR01CA178454 · NCI · UNIVERSITY OF CINCINNATI · PI CHEN, JIANJUN · 2014 to 2018
$1.7M
NCI NIH HHS R01 CA178454NCI NIH HHS R01 CA211614NCI NIH HHS R01 CA214965
6 · The paper itself

Abstract

Fat mass and obesity-associated protein (FTO) single-nucleotide polymorphisms (SNPs) have been linked to increased body mass and obesity in humans by genome-wide association studies (GWAS) since 2007. Although some recent studies suggest that the obesity-related SNPs in

Indexed as

AMLcancerfat mass and obesity-associated protein (FTO)FTO inhibitorsGBMm6A demethylasemRNA N6-methyladenosine (m6A)obesity

Identifiers

PMID30105001
PMCPMC6077364
OpenAlexW2887077046

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.